Longtime collaborators Phoenix Nuclear Labs and Shine Medical Technologies have entered into a supply and development agreement. Phoenix has agreed to provide neutron generators for use by Shine in its planned molybdenum-99 manufacturing facility. Shine will provide Phoenix support to improve its technology.
Shine Medical Technologies has signed a deal agreeing to supply GE Healthcare with the medical isotope molybdenum-99 once its manufacturing facility starts operation. A regulatory decision is pending for the Janesville, Wis., facility. It is expected to start operations by 2017.
Nordion is set to receive its first batch of molybdenum-99 isotopes from Russian firm Isotope. The shipment, of which Nordion is not specifying the amount, will "help alleviate the impact of the planned NRU reactor shutdown currently intended for mid-May 2011," Nordion said.
The U.S. Department of Energy's National Nuclear Security Administration has awarded NTP Radioisotopes, a unit of the Nuclear Energy Corporation of South Africa, a contract worth $25 million for the production of the medical isotope molybdenum-99 using low-enriched uranium. NTP Radioisotopes will be working with the Australian Nuclear Science and Technology Organisation in this initiative.
The European Commission is calling on European Union states and the European Parliament to seriously consider and promote new methods for the production of the medical isotope technetium-99m. The commission said the seven reactors producing the vast majority of the isotope "are approaching the end of their lifespan."